Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Broadcom
AVGO
|
$15.5B |
| 2 |
Apple
AAPL
|
$4.76B |
| 3 |
Microsoft
MSFT
|
$1.4B |
| 4 |
NVIDIA
NVDA
|
$1.4B |
| 5 |
Cintas
CTAS
|
$1.28B |
Top Sells
| 1 |
WRK
WestRock Company
WRK
|
$316M |
| 2 |
SiriusXM
SIRI
|
$241M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$181M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$150M |
| 5 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
$139M |
Sector Composition
| 1 | Technology | 31.06% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 11.53% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTEM
4201
DELISTED
Molecular Templates, Inc.
MTEM
| $66.4K | ﹤0.01% | 47,231 +5,240 | +12% | +$7.36K |
|
4202
FingerMotion
FNGR
$89.7M
| $66.1K | ﹤0.01% | 30,327 | – | – |
|
4203
Nocera
NCRA
$21.7M
| $65.9K | ﹤0.01% | 56,780 +6,500 | +13% | +$7.54K |
|
4204
Repare Therapeutics
RPTX
$71.7M
| $65.8K | ﹤0.01% | 19,128 -7,416 | -28% | -$25.5K |
|
4205
GlucoTrack
GCTK
$3.8M
| $65.5K | ﹤0.01% | +27,161 | New | +$65.5K |
|
|
RGF
4206
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
| $65.1K | ﹤0.01% | 162,851 +5,943 | +4% | +$2.38K |
|
4207
Inhibikase Therapeutics
IKT
$134M
| $65.1K | ﹤0.01% | 50,065 +12,735 | +34% | +$16.6K |
|
|
AMLI
4208
DELISTED
American Lithium Corp. Common Stock
AMLI
| $64.8K | ﹤0.01% | 115,650 | – | – |
|
|
LUXH
4209
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
| $64.8K | ﹤0.01% | 769,896 +609,955 | +381% | +$51.3K |
|
|
VSEE
4210
VSee Health, Inc. Common Stock
VSEE
$9.47M
| $64.5K | ﹤0.01% | +43,304 | New | +$64.5K |
|
4211
MIND Technology
MIND
$80.7M
| $64K | ﹤0.01% | 16,697 +2,448 | +17% | +$9.38K |
|
|
PROC
4212
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
| $64K | ﹤0.01% | 28,938 | – | – |
|
|
VIVS
4213
VivoSim Labs, Inc. Common Stock
VIVS
$6.34M
| $63.9K | ﹤0.01% | 125,479 +15,116 | +14% | +$7.7K |
|
4214
Tenax Therapeutics
TENX
$27.3M
| $63.6K | ﹤0.01% | 18,390 +7,349 | +67% | +$25.4K |
|
4215
Pulmatrix
PULM
$18M
| $63.3K | ﹤0.01% | 29,581 +3,108 | +12% | +$6.65K |
|
4216
EUDA Health Holdings
EUDA
$76.5M
| $63.2K | ﹤0.01% | 16,038 | – | – |
|
4217
Allot
ALLT
$362M
| $63.1K | ﹤0.01% | 21,262 | – | – |
|
4218
OneMedNet
ONMD
$39.6M
| $62.5K | ﹤0.01% | 102,247 -83,188 | -45% | -$50.9K |
|
4219
Oramed Pharmaceuticals
ORMP
$90.2M
| $62.1K | ﹤0.01% | 25,455 | – | – |
|
4220
Moleculin Biotech
MBRX
$11.9M
| $62K | ﹤0.01% | 21,818 +2,062 | +10% | +$5.86K |
|
4221
Senti Biosciences
SNTI
$38.5M
| $61.7K | ﹤0.01% | 27,293 -218,297 | -89% | -$493K |
|
4222
MMTec
MTC
$24.5M
| $61.3K | ﹤0.01% | 118,568 +22,844 | +24% | +$11.8K |
|
4223
Innoviz Technologies
INVZ
$335M
| $61.2K | ﹤0.01% | 73,873 -196,747 | -73% | -$163K |
|
|
NIXX
4224
Nixxy, Inc. Common Stock
NIXX
$35.4M
| $61.1K | ﹤0.01% | 22,291 +9,152 | +70% | +$25.1K |
|
|
QTI
4225
DELISTED
QT Imaging Holdings, Inc. Common Stock
QTI
| $60.6K | ﹤0.01% | 85,455 +6,717 | +9% | +$4.76K |
|